Skip to main content
Clinical Trials/NCT02542774
NCT02542774
Unknown
Not Applicable

Sex Differences in the Risk of Cardiovascular Diseases Associated With Diabetes: an Examination of Variation in Health Service Delivery

University College, London1 site in 1 country80,000 target enrollmentAugust 2015

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Diabetes Mellitus
Sponsor
University College, London
Enrollment
80000
Locations
1
Primary Endpoint
First occurrence of cardiovascular disease
Last Updated
10 years ago

Overview

Brief Summary

To evaluate the risk of cardiovascular events associated with medication use for controlling blood glucose, blood pressure and cholesterol levels in men and women with diabetes treated in primary care

Detailed Description

The management and treatment of adult diabetes is far from optimal. The most recent report from the National Diabetes Audit showed that only one in three people with diabetes are achieving recommended standards for controlling blood glucose, blood pressure and cholesterol levels; and only three in five received basic care processes to reduce their risk of diabetes-related complications such as blindness, amputation and kidney disease. Women did 15% worse than men, which may explain some of the reported higher excess risk of coronary heart disease and stroke, consequent to diabetes in women than men. More efficient and equitable care in people with diabetes could lead to substantial cost savings, and would improve the lives of women and men currently living with diabetes. The objective of this research isto evaluate the risk of cardiovascular events associated with medication use for controlling blood glucose, blood pressure and cholesterol levels in men and women with diabetes treated in primary care.

Registry
clinicaltrials.gov
Start Date
August 2015
End Date
November 2016
Last Updated
10 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients with diabetes at or before study entry, and participants who develop new-onset diabetes during follow-up.
  • Age ≥ 18 years
  • Data collected in the period 1997-2010
  • Minimum time since registration of 1 year
  • Minimum of 1 year of up to standard data (CPRD quality standard)

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

First occurrence of cardiovascular disease

Time Frame: 10 years

First recorded diagnosis of cardiovascular disease during follow-up: stable angina, unstable angina, myocardial infarction, unheralded coronary death, heart failure, transient ischaemic attack, ischaemic stroke, subarachnoid haemorrhage, intracerebral haemorrhage, peripheral arterial disease, abdominal aortic aneurysm, ventricular arrhythmia, cardiac arrest, or sudden cardiac death

Secondary Outcomes

  • Cardiovascular mortality(10 years)
  • All cause mortality(10 years)

Study Sites (1)

Loading locations...

Similar Trials